Form D · Biotechnology
Q-State Holdings, Inc.
Cambridge, MA · CIK 0001756811
Offering snapshot reported Feb 14, 2020 · SEC filing
- Reported sold
- $21.2M Offering amount: $41.2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Feb 10, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2020 | Initial | $21,218,527 | No comparison | 3 | SEC filing |
| Oct 25, 2018 | Initial | $64,831,545 | No comparison | 51 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-360663
Source: Form D, filed Feb 14, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Mark Evenstad | Director |
| Jonathan Fleming | Director, Executive |
| Matthew Fox | Executive |
| Steven Hyman | Director |
| David Knudson | Director |
| Dave Knudson | Director |
| Michael La Cascia | Executive |
| David Margulies | Director, Executive |
| Chad Martinson | Director |
| Matthew Might | Director |
| Andrew Ross | Director |
| Jonathan Thomas | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Q State Biosciences, Inc. 179 Sidney Street
Cambridge, MA, 02139
Cambridge, MA, 02139